Camouflaged blood cells: Low-technology bioengineering for transfusion medicine?

This publication has 28 references indexed in Scilit:

• Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity
  American Journal of Hematology, 1997
• Long circulating, cationic liposomes containing amino‐PEG‐phosphatidylethanolamine
  FEBS Letters, 1994
• Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched Blood
  New England Journal of Medicine, 1990
• In Vivo Evaluation of a Pyridoxalated-Hemoglobin-Polyoxyethylene Conjugate
  Biomaterials, Artificial Cells and Artificial Organs, 1988
• Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine Deaminase
  New England Journal of Medicine, 1987
• Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy
  Transfusion, 1987
• Broadening the base of a rare donor program by targeting minority populations
  Transfusion, 1986
• Frequency of Antibodies to Various Antigenic Determinants in Polytransfused Patients with Homozygous Thalassaemia in Greece
  Vox Sanguinis, 1971
• The toxicity of high molecular weight polyethylene glycols; chronic oral and parenteral administration
  Journal of the American Pharmaceutical Association (Scientific ed.), 1947